Angiotensin Receptor Blockers – finally the evidence is coming in: IDNT and RENAAL

This publication has 10 references indexed in Scilit:

• Medical malpractice, murder and the academic community: trouble ahead
  International Journal of Cardiology, 2001
• Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure: The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators
  International Journal of Cardiology, 2001
• Chronic stable angina and its treatment; Why Cinderella never gets to the ball?
  International Journal of Cardiology, 2000
• Disagreement between drug effects on autonomic function and mortality: another unreliable surrogate endpoint in heart failure?
  International Journal of Cardiology, 2000
• The effects of chronic, sustained-release moxonidine therapy on clinical and neurohumoral status in patients with heart failure
  International Journal of Cardiology, 2000
• Omapatrilat — the ups and downs of an exciting but complicated new drug
  International Journal of Cardiology, 2000
• Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
  The Lancet, 2000
• Heart failure 99 — the Moxcon story
  International Journal of Cardiology, 1999
• Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure
  Circulation, 1999
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
  Published by Elsevier ,1997